Granulocyte-macrophage colony-stimulating activty (GM-CSA) can be produced by a variety of normal cell types including mononuclear phagocytes, activated T lymphocytes, endothelial cells, and fibroblasts. Recent evidence shows that a major role of the monocyte-macrophage is the recruitment of environmental cells, i.e., fibroblasts, to produce GM-CSA. In this study we have identified interleukin 1 (IL-i) as a monokine that stimulates fibroblasts to produce and release GM-CSA and prostaglandin E2 (PGE2). Both purified human monocyte-derived IL-I and human recombinant ILiA (10-10 M) can be substituted for monocyteconditioned medium in stimulating fibroblast GM-CSA and PGE2 production. Both forms of IL-1 stimulate fibroblasts to produ6e GM-CSA and PGE2 in a dose-dependent fashion. The fibroblkst-stimulating activity found in monocyte-conditioned medium was completely blocked by anti-I-iA. We conclude that monocytes produce IL-1, and that monocyte-derived IL-i induces fibroblasts to produce GM-CSA and PGE2.
Introduction
Granulocyte-macrophage colony-stimulating activity (GM-CSA)' represents a family of glycoproteins that promote differentiation of hematopoietic progenitor cells to mature granulocytes and macrophages. Clonal proliferation of human neutrophil and macrophage progenitors in vitro depends upon the continuous presence of GM-CSA. A variety of cell types, including mononuclear phagocytes (1, 2) , T lymphocytes (3, 4) , vascular endothelial cells (5, 6) , and fibroblasts (7) , can produce GM-CSA. Other reported sources of GM-GSA are either not adequately characterized as to cell type, or are established tumor cell lines in which physiologic relevance is questionable. Although many normal cell types are reported to produce GM-CSA, they do require stimulation with exogenous modulators such as endotoxin (8) (9) (10) or mitogens (11, 12) . Several groups have suggested that monocytes and T lymphocytes interact to 1; GM-CSA, granulocyte-macrophage colony-stimulating activity; hrIL-1, human recombinant interleukin 1; IL-1, interleukin 1; LPS, lipopolysaccharide; MRA, monocyte-derived recruiting activity; PGE2, prostaglandin E2; pI, isoelectric point. modulate the production of GM-CSA (13) (14) (15) . These investigators have demonstrated that incubation of monocytes with T lymphocytes in the presence of antigen or mitogen produces significantly more GM-CSA than either cell type incubated alone.
Recently, Bagby et al. (I16-18) have proposed that the major role of the monocyte-macrophage in granulopoiesis is not by the production of GM-CSA, but by the recruitment of other cells, i.e., T lymphocytes, endothelial cells, and neonatal skin fibroblasts, to produce GM-CSA. These authors have described a nondialyzable factor or factors present in monocyte-conditioned medium that stimulates the production of GM-CSA by these accessory cells. They have termed this monokine as monocyte-derived recruiting activity (MRA), and have also shown that endotoxin augments monocyte production of MRA (19) . Thus, MRA may be a key biologic regulator of GM-CSA production and consequently of granulopoiesis.
Monocyte products have also been associated with chronic tissue inflammation and elevated prostaglandin E2 (PGE2) levels at the site of injury (20) . Monocytes or macrophages actively modulate fibroblast proliferation and prostaglandin production. Monocyte-conditioned medium contains a factor that results in a 50-200-fold stimulation of PGE2 biosynthesis from dermal fibroblasts (21) , synovial cells (22) , and lung fibroblasts (23) . This monocyte-derived factor has recently been identified as interleukin 1 (IL-i) (24, 25) .
In this study, we have identified the monokine that stimulates fibroblasts to produce and release GM-CSA and PGE2 as IL-1. Both purified monocyte-derived IL-I and human recombinant (hr) IL-I reproduce the biologic activity found in monocyteconditioned medium. In addition, a polyclonal antibody to IL-1 completely abolishes the biologic activity of MRA found in monocyte-conditioned medium.
Methods
Isolation ofperipheral blood monocytes. Peripheral blood and bone marrow were obtained from normal donors who had given informed consent. Peripheral blood leukocytes were isolated after semicontinuous flow pheresis (26) . The buffy coat was diluted with two volumes of Hanks' balanced salt solution without calcium and magnesium and was centrifuged at 150 g for 10 tnin to remove platelets. This cell suspension was centrifuged over Ficoll-Hypaque (specific gravity 1.078) to remove contaminating granulocytes and erythrocytes. The mononuclear cells at the interface were collected and separated into two populations, monocytes and lymphocytes, by elutriation centrifugation as previously reported (27, 28) . Briefly, counterflow centrifugation elutriation was performed using a Sanderson-designed separation chamber fitted to a Beckman model J-21C centrifuge (Beckman Instruments, Inc., Fullerton, CA). Up to 1.5 x 109 mononuclear cells were loaded into the chamber and elutriation was performed at 10°C with flow rates of 18 and 28 ml/min against a force of 867 g (3,000 rpm). Each cell fraction was collected by centrifugation (300 g for 10 min), and the cell volume profile was determined with a Particle Data, Inc. (Elmhurst, IL) System 80 pulse height analyzer. Using this technique, monocytes (380 ,um3 modal volume) were collected as a homogeneous population. Both the separated monocytes as well as unseparated peripheral blood mononuclear cells were further subjected to 2-aminoethylisothiouronium bromide hydrobromide-treated sheep erythrocyte rosette depletion to remove T lymphocytes before use. Non-rosetting cells were separated by centrifugation through Ficoll-Hypaque. The purity of nonrosetting cells was determined by using OKT3 (Ortho Pharmaceutical, Raritan, NJ) monoclonal antibody and indirect immunofluorescence with fluorescein-conjugated goat antimouse IgG (Cappel Laboratories, Cochranville, PA). The cells were analyzed with both fluorescence microscopy and a Coulter Electronics Inc. (Hialeah, FL) model C flow cytometer. Background staining was determined on cells treated with nonimmune mouse immunoglobulins and second antibody. In addition, the monocyte monoclonal antibody LeuM3 (Becton, Dickinson & Co., Sunnyvale, CA) was used for analysis of monocyte specificity and compared with cytochemical staining for monocytes.
Monocytes were identified on cytocentrifuge prepared slides stained with Wright's Giemsa and nonspecific esterase using alpha naphthal acetate as substrate (29) . The monocyte populations used in all experiments described contained <2% OKT3-positive and >98% LeuM3-positive and >98% nonspecific esterase-positive cells.
Monocyte-conditioned medium studies. Various cell concentrations ofseparated fresh and cryopreserved monocyte populations were cultured for 2 d in alpha-minimum essential medium containing 6% fetal bovine serum with and without 10-6 M indomethacin. This concentration of indomethacin prevents prostaglandin production by normal monocytes and macrophages (30 Endotoxin assay. All culture materials used were tested for the presence of endotoxin using the Limulus lysate assay (Sigma Chemical Co., St. Louis, MO) (34) . The lysate used in these studies can detect levels of endotoxin as low as 50 pg/ml. Only culture medium containing <50 pg/ml endotoxin were used except where endotoxin was intentionally added.
Fibroblast cultures. Human lung fibroblasts (CL 202) were obtained from the American Type Tissue Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. In the experiments described, fibroblasts from the first to the tenth passage were used; and the cell density ranged from 1 to 5 X 104 cells per square centimeter. Cells were subcultured by brief ( min, 37°C) treatment with 0.05% trypsin/0.02% disodium EDTA (wt/vol in PBS) and resuspended in fresh Dulbecco's modified Eagle's medium + 10% fetal bovine serum and reseeded at a 1:5 dilution in 35-mm culture plates. At least 24 h were allowed to elapse after initial seeding or subculture to obtain confluence before an experiment was begun. The fibroblast cell culture medium was replaced with 10-50% monocyte-conditioned medium, with or without a 1:100 dilution of the IgG fraction ofrabbit anti-human IL-1, various concentrations ofhuman IL-I (purified or recombinant IL-1), or control medium diluted with fibroblast culture medium, and the cultures were returned to the incubator for an additional 24 h. Controls contained diluted medium but no fibroblast cells. After 24 h, the medium was aspirated and centrifuged (200 g, 5 min), and the supematants were either assayed for GM-CSA or PGE2 the same day or stored at -20°C until tested.
GM-CSA assay. Low-density bone marrow cells from normal volunteers were prepared by centrifugation over Ficoll-Hypaque. Cell suspensions were depleted of monocytes and T lymphocytes by two sequential adherences to culture plates for I h each after which the nonadherent cells were subjected to incubation with washed 2-aminoethylisothiouronium bromide hydrobromide-treated sheep erythrocytes followed by centrifugation through Ficoll-Hypaque. The nonadherent, nonrosetting, low-density bone marrow cells contained <2% monocytes and <2% T lymphocytes when analyzed for immunofluorescence against LeuM3 and OKT3 monoclonal antibodies, respectively. For each sample, 5 X 10 T lymphocyte-depleted, nonadherent, light density bone marrow cells were cultured in 1 ml of 0.3% agar containing alpha-minimum essential medium supplemented with 10% fetal bovine serum. Sources ofGM-CSA were 10% conditioned medium from the various monocyte or fibroblast cultures, or supernatant of the human bladder carcinoma cell line 5637 at 5%, which served as a positive GM-CSA control. The negative control contained 10% vol/vol alpha-medium alone. Colonies (>40 cells) and clusters Briefly, [3HjPGE2 (Amersham Corp., Arlington Heights, IL) was diluted in Sorenson's buffer to obtain 2,000-3,000 cpm/0. I ml. PGE2 standards were prepared in Sorenson's buffer in the range from 10 to 0.020 ng/ ml. Anti-PGE2 was reconstituted and titrated to give a working dilution such that 45-55% ofthe total counts would bind. All samples (conditioned medium from monocytes or resulting fibroblast cultures) including standards and controls were run in duplicate. A charcoal-dextran buffer was used to bind the free [3HJPGE2 to the charcoal, which was pelleted leaving the [3HJPGE2 that was bound to the antibody to be counted in the supernatant. A standard curve was constructed for each assay after calculating the percent specific binding of the standards and unknowns by plotting logit %B (where %B is the percent specific binding) versus log PGE2 concentration for each standard, and the unknown concentrations were read from this curve.
Results
In four experiments, summarized in Table I , monocytes cultured in the absence of endotoxin (LPS) do not produce biologically active GM-CSA as measured by the ability of their conditioned medium to stimulate nonadherent, T lymphocyte-depleted human bone marrow cells to produce granulocyte and macrophage colonies. This observation is consistent with previous published data (10, 19) . In contrast, stimulation of 105 monocytes/ml by as little as 10 ng/ml of LPS results in biologically detectable GM-CSA (Table II) . In addition, no detectable PGE2 is seen in the conditioned medium of monocytes cultured in the absence of LPS; whereas detectable PGE2 is seen when 10 monocytes/ ml have been stimulated with 10 ng/ml of LPS. Table II shows that monocytes are not dependent on the addition of LPS to release a factor (monokine), which causes fibroblasts to produce and release GM-CSA. LPS addition, however, does augment the production of this monokine such that conditioned medium from as few as 5 X 103 monocytes/ml will stimulate maximal colony and cluster formation in the granulocyte-macrophage colony assay. The amount of PGE released by the cultured fibroblasts is also greater in the presence of added LPS. Although not shown, endotoxin (10 ng to 1 jig/ml) diluted in complete medium did not stimulate fibroblast monolayers to produce GM- Monocyte-conditioned medium was collected from monocytes cultured in the presence or absence of 10 ng/ml endotoxin on the second day of culture, diluted 1:2 with complete medium, and placed on fibroblast monolayers for 24 h after which the fibroblast supematant was harvested and assayed for GM-CSA and PGE2. ND, not done. * Results are expressed as means± 1 SEM.
CSA. Addition of 10-6 M indomethacin at the time ofmonokine production or at the time of monokine stimulation ofGM-CSA production by fibroblasts had no effect on the amount of GM-CSA detected but completely inhibited PGE2 production by fibroblasts. The resultant fibroblast-conditioned medium stimulated by monokine obtained from 10 monocytes/ml and cultured in the absence ofindomethacin contained 221 ± 19 colonies and 3,840 pg/ml PGE2; whereas fibroblast-conditioned medium obtained from similar cultures in the presence of 10-6 indomethacin contained 217±11 colonies and <20 pg/ml of PGE2. No differences in results were seen whether monocytes were used immediately after separation or whether monocytes were used after cryopreservation for various lengths of time.
Next we determined the time course of GM-CSA production by fibroblast cultures stimulated with monocyte-conditioned medium. Fig. 1 shows that detectable GM-CSA by fibroblasts did not appear until 4 h ofculture in the presence of 50% monocyte-conditioned medium with maximal levels detected by 8 h of culture. This level was maintained through 48 h of culture. Similar results were seen when IL-1 was substituted for monocyte-conditioned medium. Based upon these results, we cultured fibroblasts in the presence of monocyte-conditioned medium or IL-I for 24 h in all subsequent studies.
Purified human monocyte IL-I has the same effect upon fibroblast monolayers as crude monocyte-conditioned medium (Fig. 2) . A dose response for both GM-CSA and PGE2 production by fibroblasts occurs when between 1 and 4 U/ml of purified IL-I are cultured for 24 h with human fibroblasts. Similarly, recombinant IL-I when added to fibroblast cultures for 24 h, also showed a dose-response effect on the ability of fibroblasts to produce and release GM-CSA and PGE2 (Fig. 3) . Purified or recombinant IL-I alone had no effect on the colony assay for CFU-GM or the radioimmunoassay for PGE2.
As further proof that the activity found in monocyte-conditioned medium was IL-1, studies were conducted with an antibody to IL-I (anti-IL-1). Table III shows that a 1:100 dilution ofthis antibody completely blocked the stimulation offibroblast GM-CSA production seen by 50% monocyte-conditioned medium collected in the absence of LPS. A 1:100 dilution of anti-IL-I significantly reduced but did not completely block stimulation of fibroblasts to produce GM-CSA by 50% monocyteconditioned medium collected in the presence of 100 ng of LPS. However, when only 10% ofthis monocyte-conditioned medium was placed on fibroblast monolayers, all GM-CSA activity was abolished in the presence ofantibody. To show that the presence of the anti-IL-I did not affect the colony assay, anti-IL-I was added together with conditioned medium from the bladder carcinoma cell line 5637. Anti-IL-l had no effect on colony formation. In addition, anti-IL-1 does not appear to have a direct effect on the production of GM-CSA by fibroblast monolayers. (Table IV) , monokine was added to fibroblast monolayers for 8 h. At this time, the fibroblast-conditioned medium was removed and saved for assay. The fibroblast monolayer was washed with complete medium and then replaced with either complete medium or medium containing anti-IL-1 for an additional 16 h of culture. Assay of this 16-h conditioned medium for GM-CSA showed that there were no differences in the ability of fibroblasts to continue to produce and release GM-CSA in the presence or absence of anti-IL-l .
In the course of these studies a second hrIL-1 (RO06T) became available with an amino acid sequence starting at position 1 12 instead of 71. This site is closer to the reported N-terminus (amino acid 117) for human monocyte-derived IL-I with a neutral pl (36). As shown in Table V , R006T hrIL-l stimulated fibroblasts to produce GM-CSA at a 1.0-1.5 log lower concentration than that seen by R006B hrIL-1. Because the molecular weight of R006T hrIL-I is 17,000, it can be calculated that the amount necessary to stimulate confluent fibroblasts to produce detectable GM-CSA is -101O0 M. In order to determine whether the secretion of IL-I by cultured monocytes and GM-CSA production by stimulated fibroblasts depended on de novo protein synthesis, experiments were carried out to evaluate the effects of cycloheximide on both IL-1 and GM-GSA production. As outlined in Table VI , the addition of 10 lAg of cycloheximide reduced the secretion of IL-1 by monocytes to 15% of control and GM-CSA production by fibroblasts to 4% ofcontrol. Prior to assay for GM-CSA, all media were extensively dialyzed to eliminate the inhibitor. Thus, GM-CSA is both produced and released by fibroblasts and IL-l is also produced and released during the culture of monocytes.
Finally, colonies were fixed and stained and classified into three subtypes: pure neutrophilic granulocyte colonies showing only chloroacetate esterase-positive cells, mixed granulocytemacrophage colonies with a mixture of chloroacetate esterasepositive cells and butyrate esterase-positive cells, and pure macrophage colonies with only butyrate esterase-positive cells. Table  VII shows that all three subtypes of colonies were observed at both 7 and 14 d of culture. Higher numbers of granulocyte colonies were seen at 7 d of culture while samples analyzed on day 14 exhibited an increase in the percentage of macrophage colonies. Thus IL-I stimulates fibroblasts to produce a GM-CSA. 
Discussion
The results presented in this study have confirmed that cultured monocytes produce and release a monokine that stimulates fibroblasts to produce and release GM-CSA and POE2 (18, 20) . This monokine has been identified as IL-I since both purified and recombinant IL-I can mimic the activity found in monocyte conditioned medium. In addition, a polyclonal rabbit antibody specific for human monocyte IL-I completely abolished the ability of monocyte-derived monokine to induce fibroblast cultures to produce GM-CSA and PGE2. Addition of monocyte-conditioned medium or IL-I to fibroblast monolayers results in a marked increase in GM-CSA produced with detectable levels being found after 4 h of incubation. Maximum levels occurred between 8 and 48 h of cultures ( Fig. 1) . While endotoxin (LPS) stimulated increased levels of IL-I production by monocytes, fibroblast cultures did not produce GM-GSA in the presence or absence of LPS. Thus, in this system, LPS appears to exert its effect on colony formation through an increase in IL-1 production by monocytes. In this report we have shown that fibroblast PGE2 production was also stimulated by monocyte-conditioned medium or IL-1. This has been previously reported by others (21) (22) (23) . Because previous reports have suggested that PGE2 may counteract the stimulatory effects of GM-CSA by suppressing CFU-GM proliferation (37) or may inhibit production of GM-CSA by stimulated monocytes (38) , we cultured both monocytes and fibroblasts in the presence and absence ofindomethacin. While PGE2 production was completely inhibited by the addition of indomethacin (10-6 M), we were unable to find increased concentrations ofdetectable GM-CSA in the supernatant ofendotoxinstimulated monocytes or in the supematants offibroblast cultures stimulated with monocyte-conditioned medium or IL-1. These results indicate that the amount of PGE2 synthesized by stimulated fibroblasts (10-9 to 10-8 M) in this system does not produce an inhibitory effect on fibroblast GM-GSA production. This is probably due to the fact that PGE2 inhibits mainly macrophage colonies except at concentrations > 10-6 M (39).
Recently, Bagby et al. (16) (17) (18) have demonstrated that GM-CSA production by T lymphocytes, endothelial cells, and fibroblasts is stimulated by a soluble monocyte product which they have termed monocyte-derived recruiting activity (MRA). They have also proposed that MRA production may represent the means by which monocytes regulate steady-state granulopoiesis.
In this study, we have been able to corroborate that monocytes produce a factor which induces fibroblasts to produce GM-GSA (Table II) and have identified this factor as interleukin 1 (Table   IV) . Whether IL-I is a universal monokine and will also stimulate other cells (i.e., T lymphocytes or endothelial cells to produce GM-GSA) is not known at present. In addition, it is unknown whether IL-I may also stimulate these same types of accessary cells to produce other growth factors such as burst-promoting activity (BPA), megakaryocyte-GSA, or mixed granulocytemacrophage CSA. Studies on the production of these other growth factors as well as the interaction of endothelial cells and IL-l are currently in progress.
Human monocyte-derived IL-I represents a family of polypeptides with multiple biologic activities. Recently, considerable interest has been generated in the study of IL-I as a mediator of host responses to infection, injury and various immunological reactions (20) . How many of the biologic activities ascribed to IL-1 are due to a single substance has only begun to be studied with the cloning ofcDNAs coding for human monocyte-derived IL-1 (33) . At present, there seems to be a minimum of at least two distinct forms of IL-1 (33, 40) , which are based on two major isoelectric points, pI 7 and pl 5. Because of the role of IL-1 in neutrophil release from bone marrow (41) and its role as a chemoattractant for neutrophils and monocytes in vitro (42, 43) , it is perhaps not surprising that it may also play a role in granulocyte and monocyte production. The two purified hrILl's with a pI 7 (33) used in this study were both shown to be active in stimulating fibroblast monolayers to produce and release both GM-CSA and PGE2. RO06T hrIL-1, containing an amino acid sequence starting at position 1 12 which is close to the Nterminus of IL-1, stimulated fibroblasts to produce detectable GM-CSA at a dose of about 10-10 M. Thus, elimination of 111 of the 1 16 amino acids that are part of the precursor peptide did not prevent induction of GM-CSA production by cultured fibroblasts. Whether other forms (i.e., pI 5) will also possess this property remains unknown.
